In 2025, Big Pharma plans to pursue acquisitions to replace lost revenue from expiring patents on major drugs, focusing on obesity and oncology markets.
Obesity is a global crisis by 2035, with 1.5 billion adults affected. A shift from trial-and-error approaches to precision medicine is crucial for effective treatment.